Announcements Announcements 2022 Caris Life Sciences and Hummingbird Bioscience Enter Into Collaboration to Advance Clinical Development of Anti-HER3 Therapy Continue Reading
Announcements Announcements 2022 Hummingbird Bioscience Announces Two HMBD-002 Poster Presentations at the Society for Immunotherapy of Cancer 2022 Annual Meeting Continue Reading
Announcements Announcements 2022 Hummingbird Bioscience to Attend the Credit Suisse 31st Annual Healthcare Conference Continue Reading
Announcements Announcements 2022 Hummingbird Bioscience Holds Opening Ceremony for Singapore Science Park Office and Research Facilities Continue Reading
Announcements Announcements 2022 Hummingbird Bioscience Chief Scientific Officer Jerome Boyd-Kirkup to Present at the 2nd Annual VISTA Virtual Symposium Continue Reading
Announcements Announcements 2022 Hummingbird Bioscience Announces Trial in Progress Poster Presentation at the European Society for Medical Oncology Congress 2022 Continue Reading
Announcements Announcements 2022 Hummingbird Bioscience to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference Continue Reading
Announcements Announcements 2022 Hummingbird Bioscience Publishes Preclinical Data Demonstrating Therapeutic Potential of HMBD-002 in VISTA-expressing Cancers Continue Reading
